Durvalumab vs Metoprolol

## Durvalumab vs Metoprolol: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Metoprolol**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Metoprolol**: Selective beta-1 adrenergic receptor blocker.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Metoprolol — 3-7 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Metoprolol — C15H25NO3.

**Molecular Weight**: Durvalumab — N/A; Metoprolol — 267.3640 g/mol.

**Type**: Durvalumab — Antibody; Metoprolol — Small molecule.